Understanding the practice landscape of marginal zone lymphoma in Southeast and East Asia
Authors:
- Jason Yongsheng ChanJCJason Yongsheng Chan
- Nia Novianti SiregarNSNia Novianti Siregar
- Anna Mira LubisALAnna Mira Lubis
- Noorainun YusofNYNoorainun Yusof
- Shin Yeu OngSOShin Yeu Ong
- Lee Ping ChewLCLee Ping Chew
- Priscilla CaguioaPCPriscilla Caguioa
- Jay DatukanJDJay Datukan
- Suporn ChuncharuneeSCSuporn Chuncharunee
- Do Huyen NgaDNDo Huyen Nga
- Tran-Der TanTTTran-Der Tan
- Bor-Sheng KoBKBor-Sheng Ko
Open Access
- 10 March 2026
- journal article
- Published by Elsevier in Blood Global Hematology
- Vol. 2 (2)
Abstract
No abstract availableFunding Information
- Duke-NUS Medical School (Duke-NUS-KBrFA/2025/0090)
- SingHealth (08/FY2023/EX/27-A65)
- National Medical Research Council (TA21jun-0005)
- National Medical Research Council (CIRG25jan-0007)
- National Medical Research Council (OFLCG-23May0039)
- National Medical Research Council (CG21APR2002)
- Tanoto Foundation
- National Cancer Centre of Singapore
- Ministry of Health -Singapore
This publication has 40 references indexed in Scilit:
- Delphi consensus recommendations on treatment for advanced-stage marginal zone lymphoma in South KoreaAnnals of Hematology, 2024
- Best–Worst Scaling and the Prioritization of Objects in Health: A Systematic ReviewPharmacoEconomics, 2022
- Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2020
- JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-2. Marginal zone lymphoma (MALT lymphoma/extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue and splenic marginal zone lymphoma)International Journal of Hematology, 2019
- Subtype‐specific epidemiology of lymphoid malignancies in Taiwan compared to Japan and the United States, 2002‐2012Cancer Medicine, 2018
- Gender and ethnic differences in incidence and survival of lymphoid neoplasm subtypes in anAsian population: Secular trends of a population‐based cancer registry from 1998 to 2012International Journal of Cancer, 2015
- Survival of patients with marginal zone lymphomaCancer, 2012
- Phase II trial of rituximab plus CVP combination chemotherapy for advanced stage marginal zone lymphoma as a first-line therapy: Consortium for Improving Survival of Lymphoma (CISL) studyAnnals of Hematology, 2011
- High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignanciesAnnals of Hematology, 2010
- Relapsed or refractory nongastric marginal zone B‐cell lymphoma: Multicenter retrospective analysis of 92 casesAmerican Journal of Hematology, 2009